Shuchean Chien

Canagliflozin, a novel inhibitor of sodium glucose co‐transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects

Sue Sha, Damayanthi Devineni, A. Ghosh et al. · Diabetes Obesity and Metabolism · 2011 · 292 citations

Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses

Shuchean Chien, Mark Rogge, L. G. Gisclon et al. · Antimicrobial Agents and Chemotherapy · 1997 · 215 citations · Full text

Oral Levofloxacin, Therapeutic Drug Monitoring, Pharmacokinetic Profile +10

Double-Blind Evaluation of the Safety and Pharmacokinetics of Multiple Oral Once-Daily 750-Milligram and 1-Gram Doses of Levofloxacin in Healthy Volunteers

Shuchean Chien, F. Wong, Cynthia L. Fowler et al. · Antimicrobial Agents and Chemotherapy · 1998 · 107 citations · Full text

Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects

Shuchean Chien, Andrew Chow, Jaya Natarajan et al. · Antimicrobial Agents and Chemotherapy · 1997 · 85 citations · Full text

Levofloxacin Pharmacokinetics in Children

Shuchean Chien, Thomas G. Wells, Jeffrey L. Blumer et al. · The Journal of Clinical Pharmacology · 2005 · 64 citations · Full text

Pharmacotherapy, Antimicrobial Chemotherapy, Many Pathogens +17